YTHDF2 was also related to the poor prognosis of glioma in Lin et al.’s (2020) research, and the latest research implied that stabilized YTHDF2 could enhance the growth capacity of glioblastoma (Fang et al., 2021). The gene discussed is YTHDF2; the disease is central nervous system cancer.